Chlormadinone acetate, cyproterone acetate and dienogest are potent, orally active
progestogens, which have antiandrogenic instead of partial androgenic activity. They act …

Abstract▴ The progestogen dienogest exhibits highly selective binding to the progesterone
receptor. It has high progestational and significant antiandrogenic activity, but only moderate …

This is the first double-blind, controlled, randomized study comparing the effect of different
estrogen components in oral contraceptives (OCs) on hemostasis variables. Four groups of …

For a number of haemostatic factors menstrual cycle variation has been studied. Such
variation could have clinical implications for the timing of haemostatic testing in women. It …

Background The shift towards hypercoagulation during in vitro fertilization (IVF) can lead to
the impairment of embryo implantation and placental blood circulation, which is believed to …

The aim of this review is to define the role of the combined dienogest (DNG)/estradiol
valerate (E2V) contraceptive pill, in terms of biochemistry, metabolic and pharmacological …

BACKGROUND: The study was conducted to investigate the effect of a combined oral
contraceptive (COC) containing 30 mcg ethinylestradiol and 2 mg dienogest with two …

The low-dose combined oral contraceptive of ethinylestradiol 30 μg and dienogest 2 mg was
launched in Germany in 1995, and is now the most commonly prescribed oral contraceptive …

Objectives and methods A postmarketing survey was carried out to determine the efficacy
and tolerability of Valette®(dienogest 2.0 mg and ethinylestradiol 0.03 mg) in routine …

Objective To describe the modulation of ovarian function during three medication cycles with
0.03 mg ethinyl oestradiol (EE) and 2 mg chlormadinone acetate (CMA), leading to inhibition …